Insta
Govt Sets Up New Panel To Resolve Issues Related To Foreign COVID Vaccine Supply
Pfizer BioNTech COVID-19 vaccine
In a bid to expedite the entry of the foreign manufactured Covid-19 vaccines, the Centre has constituted an interministerial panel to resolve issues relating to supply of the jabs manufactured in other countries, reports Economic Times.
The members of the panel include senior officials from law, external affairs and health ministries as well as chairman of the government's Covid-19 Task Force and NITI Aayog member Dr V K Paul.
According to the report, the panel will look to solve issues relating to supply chain, logistics and pricing. It will also examine the issue of the indemnity clause, which has been a point of contention between global vaccine manufacturers such as Pfizer and the Indian government.
The Centre has been in negotiations with Pfizer for months over the modalities to bring in the US pharma giant’s vaccines. However, there has been no breakthrough so far due to the contentious issue of indemnity clause.
It should be noted that the government is trying to scale up Covid-19 vaccination in the country. So far, three Covid-19 vaccines - Covishield, Covaxin and Sputnik V - are being used in India's vaccination drive.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
